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Accepted 21 October 2016Herein, we describe a new protocol for the silane-based surface modiﬁcation of quartz substrates for the immo-
bilization of hexa-histidine-tagged heat shock protein 10. This molecule is an attractive biomarker for the detec-
tion of ovarian cancer, particularly for possible early-stage diagnosis. The surface chemistry we have described is
used for a study of the interaction between the protein and a novel DNA aptamer via an in-house built acoustic
wave sensing platform. Quartz discs were modiﬁedwith amixed trichlorosilane adlayer and functionalized with
a nickel-NTAL moiety to allow for immobilization of the protein in a correctly-oriented fashion. All layers were
characterized by x-ray photoelectron spectroscopy to show successful layer modiﬁcation. Detection of binding
in phosphate buffered saline was determined using the EMPAS, operating at a fundamental frequency of
940MHz. Results regarding the speciﬁc binding of the DNA aptamer to the surface-immobilized protein exhibit-
ed a signiﬁcantly smaller signal compared to surfaces without protein, which comparatively yieldedmuch larger
frequency shifts. The smaller shift in frequency is attributed to the rigidiﬁcation of the bulk layer upon interaction
between probe and ligand as the overwhelming factor. This rigidiﬁcation is counteracted bymass loading effects,
in which a balance between these two factors is what contributes to the overall smaller frequency shift. Without
the binding interaction, the bulk layer does not rigidify, resulting in mass loading being the main contributor to
signal, and thus a large frequency shift is seen.
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Ovarian cancer, a deadly disease of the ovaries in the female repro-
ductive system, currently affects approximately a quarter million
women worldwide and is anticipated to kill over 14,000 women in
the US. Over 22,000 new cases are diagnosed and accounts for the
deaths of nearly 150,000 women annually [1,2]. In most cases, the dis-
ease is not detected until it has reached its late stages, resulting in the
abysmal 5-year survival rate of only 45% compared to the 99% for
women with breast cancer [2]. The only and current widely used bio-
marker-based assay for ovarian cancer is detects for the well-known
cancer antigen 125 (CA-125) [3–5], a method that has been employed
for monitoring patients for over three decades. Unfortunately, the CA-
125 assay is not viable on its own for the detection of ovarian cancer,
since the antigen is only present at elevated levels in approximately
half of patients at the early stage [3]. It is, however, present in over
90% of late-stage patients [6], which is amajor disadvantage at a diagno-
sis and prognosis stand point. Furthermore, the assay is notorious fororatories, 80 St. George Street,
978 8775.
mpson).
ne, Keenan Research Centre for
5B 1W8, Canada.
. This is an open access article underproducing signiﬁcant amounts of both false negative and false positive
results [4,7–9]. In view of the above, there is an urgent need for the de-
velopment of an assay for a system, especially a biosensor, which is ca-
pable of the detection of a biomarker for ovarian cancer in the early
stages of progression of the disease. As the ﬁrst steps towards this
goal, wemust ﬁrst evaluate proper probes against a new target protein.
Heat shock protein 10 (HSP10) has recently emerged as a potential
biomarker for ovarian cancer [10] as it is seen to promote tumour forma-
tion through suppressing apoptosis of malignant cells [11]. The protein
has been found to be elevated in concentration in the immediate tissues
surrounding a tumour within the ovary [10] and therefore, taking a
blood sample from the immediate areawould prove acceptable as a pos-
sible screening method. HSP10 is not present at elevated levels in
healthy individuals, rendering it a plausible biomarker with high speci-
ﬁcity and low chance of eliciting false positives [12,13]. It is known
that HSP10 is involved in cell proliferation during pregnancy and is
found to be released into the bloodstream at these early stages, thus it
is also known as Early Pregnancy Factor [10,14]. It is released during
pregnancy because HSP10 is also an immunosuppressant [11], thus
protecting the fetus from being attacked by the immune system of the
mother. As a result, it is difﬁcult to develop antibodies against this pro-
tein. In addition to ovarian cancer, HSP10 is also seen to be released
from proliferating liver cells during regeneration [12,15] as well as sev-
eral other cancers [12,16–18]. Therefore, this proteinmay not need to bethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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other disease cases.
In order to design and develop a biosensor for the detection of
HSP10, it is necessary to produce a probe capable of highly selective
binding of the protein, with the probe being linked to the surface of a
device of choice. Among the many molecular recognition entities such
as proteins [19,20], antibodies [21] or oligonucleotides [22,23]
employed for this purpose, the aptamer offers several desirable proper-
ties in terms of the binding of HSP10, especially in the light of the fact
that it is extremely difﬁcult to develop antibodies against this protein.
Among the oligonucleotide family, since their appearance in the
1990s, aptamers have increasingly become a popular tool for applica-
tion in novel diagnostic technologies because of their ability to provide
high afﬁnity and selective binding towards a very wide range of target
analytes [24]. Aptamers are considered to possess signiﬁcant advan-
tages over the more conventional biological probes such as antibodies
and enzymes in that they can be designed and synthesized to be capableScheme 1. (A) Molecular reagents used for surface modiﬁcation of quartz. (B) Chemical sc
immobilization.of binding to a particular target of interest, are chemically stable, and
can be produced on a commercial basis with relative ease [10,11]. An
additional attractive feature of aptamer molecules is their capability to
undergo characteristic conformational changes, which can be tailored
for detection by speciﬁc transduction techniques [25,26].
The device of choice in the present work is the electromagnetic
piezoelectric acoustic sensor (EMPAS) [27] It couples the advantages
of two sensors (thickness shear mode acoustic wave sensor and mag-
netic acoustic resonance sensor) [28] to achieve extremely high sensi-
tivity. The EMPAS is designed to detect the resonance frequency
generated from an electrode-less quartz disc. This resonance is induced
by an oscillating electromagnetic ﬁeld from a copper coil located 30 μm
under the quartz disc. Because the EMPAS can generate ultra-high fre-
quencies (up to 1 GHz), it is very sensitive to structural changes, and
viscoelastic, and mass loading properties [28]. It is noteworthy also
that the device is capable of functioning while operating in biological
ﬂuids [29,30].hematic for the surface modiﬁcation of activated bare quartz to allow for ﬁnal HSP10
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tween HSP10 and a specially designed aptamer. The work involves a
new protocol for the modiﬁcation of silica substrates in the form of
EMPAS-based quartz discs designedwith the speciﬁc goal of the surface
immobilization of hexa-histidine (His) tagged HSP10. The modiﬁcation
(Scheme 1) uses a proprietary linker that has not previously been used
with the aim of protein-surface attachment. In addition, this work also
demonstrates a selective interaction of a DNA aptamer onto the
immobilized protein that can be observed in a label-free condition in
real-time. The speciﬁc purpose of the study was to carefully examine
the nature of the interaction of the protein-aptamer pair, although it is
recognised that, in the present form, the system constitutes the reverse
of that conventionally required for biomarker detection. For biomarker
detection, one would want the probe (i.e. the DNA aptamer) to be
immobilized on the surface for the capture of the biomarker in solution.
Alternatively, the system we have developed with the biomarker
immobilized is proof-of-concept work that can be applied to detection
and possible screening or selection of multiple aptamers to any His-
tagged protein or biomolecule.
2. Experimental
2.1. Reagents
DNA aptamer MND-38 was designed by Dr. Miguel Neves (University
of Toronto) based on aDNA structure sequence of an aptamer provided by
Dr. Alexander Romaschin (St.Michael'sHospital).MND-38has the follow-
ing sequence: 5′– AACTGGTGCGGGGTGGTGGGGGATGGATGTTGCTTG
AGGGGTC – 3′ and contains no primer region. The DNA aptamer was
named afterDr.Miguel Neves (“MN”), the 4th (“D”) construct he designed
based on the 38th sequence determined from the initial SELEX screen.
Heat shock protein 10 (HSP10)was puriﬁed using Ni-afﬁnity chroma-
tography fromBL21 Rosetta E. coli cells through standard over-expression
methods. In brief, HSP10 expressionwas inducedwith 1mMisopropyl-β-
D-1-thiogalactopyranoside (IPTG) to cells in a mid-log growth phase
(A600 nm = 0.6-0.8) at 37 ˚C for 4 hours. Cells were harvested, lysed
using sonication, cell debris separated and ﬁlterd soluble cell lysate was
then chromatographically puriﬁed as previously described. The plasmid
containing the protein sequence was provided to us by Dr. Alexander
Romaschin.
2.2. Quartz disc cleaning
Quartz discs were purchased from LapTech Precision Inc.
(Bowmanville, Ontario, Canada) and were speciﬁed to be AT-cut, be
13.5 mm in diameter, and have a 20.0 MHz fundamental frequency.
The discs were cleaned with an acidic piranha solution (3/1 (v/v) of
H2SO4 and 30% H2O2) using a previously described protocol [31].
2.3. Quartz disc silanization
Cleaned, bare quartz discs after activation in the humidity chamber
are ﬁrst silanized with a mixed adlayer of 13-trichlorosilyl-tridecanoic
acid pentaﬂuorophenyl ester (PFP) [32] and octyltrichlorosilane (OTS;
Sigma-Aldrich) in a 1:1 v/v ratio. In a glovebox pressurized under nitro-
gen atmosphere, stock solutions of PFP and OTS were prepared by
mixing 10 μL of the speciﬁed linker in 10 mL of anhydrous toluene. Fol-
lowing preparation, 500 μL of each stock solution was pipetted into a
silanized test tube containing one quartz disc, allowing for full submer-
sion of the disc. Solution introduction through aliquots prevent the en-
trapment of small air bubbles/pockets underneath the disc and allows
for easier submergence of the disc without much agitation. The test
tubes containing the discs were stoppered, removed from the glovebox,
and set on an orbital shaker for a strict reaction time of 2 h.
After the allotted time, the discs were removed from the orbital
shaker and were rinsed 3 times with spectral-grade toluene, followedby sonication for 2 min. The discs were then rinsed again 3 times with
spectral-grade chloroform and then sonicated for another 2 min. Fol-
lowing this, the discs were carefully removed from the test tube and
dried with a stream of nitrogen gas. The discs were then placed into in-
dividual scintillation vials and capped.
2.4. Immobilization and activation of NTAL
A stock solution of 10 mM Nα,Nα-bis(carboxymethyl)-L-lysine hy-
drate (NTAL; Sigma-Aldrich) in dimethyl sulfoxide was ﬁrst prepared.
Silanized discs were placed into individual test tubes and introduced
to 1 mL of the NTAL stock solution in 500 μL aliquots. The test tubes
were sealed with a rubber stopper and placed on a spin place for an
overnight reaction.
The test tubes were removed from the orbital shaker and the solu-
tion inside discarded the following day. All discs were rinsed 3 times
with spectral-grade dimethyl sulfoxide and sonicated for 2 min and
was repeated with spectral-grade chloroform. After the ﬁnal rinse, the
discs were removed from the test tubes and dried with a stream of ni-
trogen gas. The modiﬁed quartz discs were placed into individual scin-
tillation vials and capped.
A stock solution of 100 mM nickel chloride hexahydrate (Sigma-
Aldrich) in deionised water was ﬁrst prepared. The NTAL-modiﬁed
discs were placed into test tubes and 1 mL of the nickel stock solution
was introduced to the discs in 500 μL aliquots, allowing for full submer-
sion of the disc. The test tubes were sealed with a rubber stopper and
placed on an orbital shaker for an overnight reaction.
The test tubes were removed from the orbital shaker and the solu-
tion inside discarded the following day. All discs were rinsed 3 times
with deionised water and sonicated for 2 min and was repeated with
spectral-grade methanol. After the ﬁnal rinse, the discs were removed
from the test tubes and dried with a stream of nitrogen gas. The modi-
ﬁed quartz discs were placed into individual scintillation vials and
capped.
2.5. His-tagged protein immobilization
A stock solution of 5 μM His-tagged HSP10 in deionised water was
ﬁrst prepared. Each disc was introduced to the protein solution in
500 μL aliquots for a total of 1 mL per disc and visually conﬁrmed to
be fully submerged. The test tubes were sealed with a rubber stopper
and placed on a spin place for an overnight reaction.
The test tubes were removed from the orbital shaker and the solu-
tion inside discarded the following day. All discs were rinsed 6 times
with deionised water. After the ﬁnal rinse, the discs were removed
from the test tubes and dried with a stream of nitrogen gas. The modi-
ﬁed quartz discs (Scheme 1) were placed into individual scintillation
vials, capped, and stored for a maximum of 1 day before analysis.
2.6. X-ray photoelectron spectroscopy characterization
Prepared quartz discs were characterized by X-ray Photoelectron
Spectroscopy (XPS) at Surface Interface Ontario (Toronto, Ontario,
Canada) with the Thermo Scientiﬁc K-Alpha instrument operating
with an Al Kα X-ray source. Four take-off angles relative to the normal
(27.5°, 42.5°, 57.5°, and 72.5°) for speciﬁed elements (C, Cl, F, N, Ni, O,
and S) were analyzed for deep-layer and surface analysis. Using the
ThermoAvantage program provided at Surface Interface Ontario, peak
ﬁtting and data analysis for each element was performed. All peaks
and graphs were calibrated according to the carbon signal at 285.0 eV
and background smoothing was set to 0.5 eV.
2.7. EMPAS measurements
The EMPAS instrument is ﬁrst primed using an arbitrary quartz disc
(i.e. not cleaned or speciﬁcally prepared) and an injection of deionised
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ﬁltered phosphate buffered saline (PBS) is ﬂown into the cell over the
quartz disc at a rate of 50.00 μL/min. During this time, the acoustic res-
onance envelope of that particular disc is found by scanning the radio
frequency generator at 940.000MHz aswell as utilizing the oscilloscope
as a visual cue. Using the LabView program, a proﬁle for the resonant
wave is outputted where the linear region of the curve is noted to ﬁnd
the amplitude atwhich the EMPASwill be operating at, which is usually
a value within the range of 25–35 mV.
Once a baseline was established on the EMPAS (~2000 s) an injec-
tion of re-annealed aptamer was made. Aptamer was re-annealed by
submerging the aptamer solution in a water bath of 90 °C for 5 min
and then shocked in an ice bath. An aptamer solution of 400 μM in
deionised water was prepared from a stock solution of 944 μMMND-
38 for injection. All samples were performedwith at least one replicate.
The baseline was allowed to restabilize after injection before the run
was stopped. The frequency shiftwas calculated by taking the difference
between before and after baseline stabilization.
3. Results & discussion
3.1. Surface preparation and characterization by XPS
When bare quartz is silanized with PFP and OTS, an increase in ﬂuo-
rine is seen as a result of the ﬂuorinated head groups on PFP. A mixed
adlayer was used for these experiments since it was seen that a
homogenic PFP layer did not provide full reaction during NTAL
functionalization. The mixed adlayer showed full reduction of the ﬂuo-
rine signal when analyzed with XPS, and therefore suggests that the
adlayer was fully functionalized with NTAL. With XPS analysis, the in-
troduction of NTAL to the surface results in a small increase in the nitro-
gen signal as well as a loss of ﬂuorine signal. The latter is a direct
consequence of NTAL functionalizing onto the PFP and dissociating the
head groups. With the introduction of nickel chloride hexahydrate, a
trace, but signiﬁcant amount of nickel is found to be present on the sur-
face. Finally, when HSP10 is immobilized, we see a large increase in car-
bon (SI 1) and nitrogen (Fig. 1), which is a direct result of protein on the
surface. A summary of selected elements eliciting proper layer forma-
tion is shown in Fig. 1. Relative atomic percentages for all analyzed ele-
ments can be found in SI 1.
Examination of the nitrogen signal reveals that two peaks are evi-
dent at 402 eV and 397 eV (SI 2), both corresponding to the two differ-
ent nitrogenous imidazole ring present in histidine [33–35]. The
increase in signal of this peak when we probe with a deeper angle sup-
ports the fact that the His-tag is present deeper in the functionalized
surface and most likely is coordinated to the nickel. This suggests that
the protein is properly oriented on the surface and it most likely
immobilized via chelation to nickel. Amine and amide bondsFig. 1. Summary of selected elements from XPS to showcorresponding to the protein should give a peak at around 400 eV34,
but the signal may be mitigated by adjacent peaks.
3.2. EMPAS speciﬁc binding measurements
It is known that the described aptamer is speciﬁc to HSP10 as a result
of its selection process through SELEX. Subsequent binding conﬁrma-
tion was performed through DNA-Native PAGE analyses as a bound
complex band was evident once HSP10 was introduced to a solution
of the MND-38 aptamer (SI 3).
With properly modiﬁed quartz surfaces, 400 μM of aptamer was
injected over the surface using the EMPAS. The measurements show
that there was a speciﬁc interaction between protein and aptamer
when protein was on the surface (Fig. 2). When aptamer is introduced
to the quartz surface modiﬁed only with the mixed PFP:OTS adlayer, a
large frequency shift is seen (Δf= 6.91 ± 2.74 kHz) and exhibits a dif-
ferent graphical proﬁle overall compared to the other samples. Alterna-
tively, when protein is present on the surface – either covalently bound
or non-speciﬁcally adsorbed – the frequency shift is signiﬁcantly dimin-
ished (Δf= 1.29 ± 0.33 kHz and Δf= 1.12 ± 0.55 kHz, respectively).
Both samples exhibit similar proﬁles.
When no protein is present on the quartz surface, the overwhelming
factor contributing to the signal is that ofmass loading. The introduction
of the aptamer causes the overall frequency to resonate at a lower value
as a result of the gravimetric changes. On the other hand, when operat-
ing with quartz surfaces modiﬁed with HSP10 protein, a signiﬁcantly
smaller frequency shift is seen when aptamer is injected onto the sur-
face. In a previous study performed, a non-speciﬁc interaction gave a
smaller frequency shift compared to a speciﬁc interaction [30]. The hy-
pothesized reason for this observed phenomenon is due to the rigidiﬁ-
cation of the bulk layer when the interaction between protein and
ligand occurs. During rigidiﬁcation, the bulk layer is capable of resonat-
ing better with the underlying quartz substrate. This allows for the res-
onant wave to propagate through the layers more effectively, thereby
allowing the system to operate at a higher frequency. The result of the
interaction of aptamer with protein on quartz surfaces corresponds to
a balance between opposing factors. Rigidiﬁcation of the bulk layer as
a result of an interaction theoretically would show a frequency shift
upwards, whereas gravimetric changes would result in a downwards
shift. As these two contributing factors oppose each other, the ultimate
result would be a diminished signal, which is evident in our EMPAS
measurements.
Reproducibility of the quartz discs with non-speciﬁcally adsorbed
protein is slightly diminished in comparison to discs with covalently
immobilized protein. The relative standard deviation (RSD) values
were calculated to be 49% and 25%, respectively. The lowered reproduc-
ibility rate (or higher RSD value) for the non-speciﬁcally adsorbed pro-
tein may be attributed to improperly oriented protein or protein wash-proper characterization of modiﬁed quartz surfaces.
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Fig. 2.EMPAS results from injection of 400 μMMND-38DNA aptamer over three differently prepared quartz surfaces. “Full Layers” refers to all characterized layers. “Adlayer Only” refers to
quartz modiﬁed only with the silane adlayer. “HSP10 Only” refers to bare quartz with protein adsorbed. (A) Graphical representation of the measured frequency shifts corresponding to
indicated prepared surfaces. (B) EMPAS data comparing all three prepared surfaces. Dotted line indicates point of aptamer injection.
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protocol we have described to covalently immobilize His-tagged
HSP10 remains superior compared to adsorbed protein as the former
provides a larger degree of control over speciﬁc protein orientation,
thereby minimizing the RSD value and enhancing reproducibility of re-
sults. By using our prepared surfaces, we can maximize reproducibility
as a result of properly immobilized protein to allow for aptamer binding.
This is further supported by the large RSDvalue seen at the samples pre-
pared with the adlayer only where no speciﬁc interaction occurs.
The peak seen in the EMPAS measurements is a result of storage of
aptamer in deionised water. When deionised is water is injected into
the EMPAS, while the ﬂow-through solvent is PBS, the peak is seen.
When PBS is injected contrarily, no peak or shift is seen as expected
(SI 4). The drift seen in the graphs is a result of the EMPAS instrument
itself, as these particular graphs are not baseline corrected.
PBS is a buffer solution containing a variety of salts and ions, which
have an effect on the resonant amplitude of the EMPAS. This is due to
the effect of the Helmholtz dielectric layer that occurs on the surface
when a liquid medium is run over. Previously, the Thompson group
has described the effect of high solute concentration on the resonant en-
velope amplitude of the EMPAS. It was stated that the resonant enve-
lope amplitude decreases as higher solute concentration is present
due to ion screening. This phenomenon reduces ion movement over
the surface which causes a reduction in the effective magnetic ﬁeld.
Movement of charge is induced by the magnetic ﬁeld, which leads to a
current that is detectable by the system. With a reduction in the
effective magnetic ﬁeld, a smaller current is induced, leading to a
reduced signal. On the other hand, inhibited ions as a result of low
salt concentrations have a reduced ability to generate a current dueto a lack of movement and thus, result in smaller resonant amplitudes
[27].
What is seen with the experiments performed with the change in
buffer conditions is a situation that lies in between the high and low sol-
ute concentration phenomenon described previously. PBS is a buffer
packed with solutes and ions. As this is our ﬂow-through buffer of
choice, itmay be creating the ion screening effect, inwhich the resonant
envelope seen is the one used. Howeverwhen deionisedwater – a solu-
tion containing no solutes or ions – is injected into the system, when it
reaches the sensing surface, a displacement of the solutes already pres-
ent in the chamber causes an increase in current and therefore, an over-
all increase in signal. As the deionisedwater portion leaves the chamber,
the signal returns back to its original baseline envelope.
4. Conclusions
We have described a novel surface modiﬁcation of quartz discs for
the immobilization of a His-tagged protein, HSP10. This modiﬁcation
has been successfully characterized by x-ray photoelectron spectrosco-
py. Additionally, we have also shown the applicability of this surface in
acoustic wave sensors for detecting aptamer binding and allows for fu-
ture applications towards other His-tagged proteins and corresponding
binding partners. The interaction seen here with the EMPAS between
aptamer and protein has provided insight into possible bulk layer phe-
nomenon, such as rigidiﬁcation, to cause a plausible increase in signal.
As such, these experiments have revealed that the EMPAS is not gravi-
metric device, but encompasses a myriad of surface interactions and
phenomena that onemay be hesitant to use for solely quantitativemea-
surements. As a result, it is more valuable for the EMPAS to be used as a
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ring. As this is preliminarywork, however, further investigation for non-
speciﬁc interactions with other proteins and aptamers still needs to be
explored. As this work will lead into involvement of clinical samples
(i.e. blood), further optimization regarding non-speciﬁc adsorption
and an anti-fouling chemistries are areas of future exploration, which
will require tedious optimization. We emphasize that this work is a
proof-of-concept for the interaction between a DNA aptamer and an
ovarian cancer biomarker and that the immobilization of a His-tagged
biomarker on quartz surfaces allows for measurement in real-time.
The biomarkers and probe described in this paper are clinically
relevant to early-stage ovarian cancer detection. Within this proof-of-
concept work, we have provided insight into the future immobilization
of a DNA aptamer-based probe onto a quartz surface as a step towards
building an EMPAS based biosensor that can detect this important bio-
marker, HSP10.
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